You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 19, 2024

TWINJECT 0.3 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Twinject 0.3, and when can generic versions of Twinject 0.3 launch?

Twinject 0.3 is a drug marketed by Impax and is included in one NDA.

The generic ingredient in TWINJECT 0.3 is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Twinject 0.3

A generic version of TWINJECT 0.3 was approved as epinephrine by BPI LABS on July 29th, 2014.

  Try a Trial

US Patents and Regulatory Information for TWINJECT 0.3

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax TWINJECT 0.3 epinephrine INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS 020800-001 May 30, 2003 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for TWINJECT 0.3

See the table below for patents covering TWINJECT 0.3 around the world.

Country Patent Number Title Estimated Expiration
Canada 2589899 PROCEDES ET DISPOSITIFS D'INJECTION DE MEDICAMENTS (MEDICINE INJECTION DEVICES AND METHODS) ⤷  Try a Trial
Russian Federation 2131748 AUTOMATIC OR MANUAL DEVICE FOR INJECTIONS OF LIQUID MEDICINAL AGENT ⤷  Try a Trial
Russian Federation 2431505 УСТРОЙСТВО ДЛЯ ИНЪЕКЦИИ ЛЕКАРСТВ (ВАРИАНТЫ) И СПОСОБЫ ЕГО ПРИМЕНЕНИЯ (DEVICE FOR DRUG INJECTION (VERSIONS) AND METHODS OF APPLICATION THEREOF) ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 2006062997 ⤷  Try a Trial
San Marino AP200700024 Metodo e apparecchio per erogare epinefrina ⤷  Try a Trial
Poland 311759 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.